View in EDS HTML Full Text PDF Full Text

Pharmacokinetics (PK) of Tiragolumab in First-in-Human Study in Patients with Mixed Solid Tumors (GO30103).

Saved in:
Bibliographic Details
Title: Pharmacokinetics (PK) of Tiragolumab in First-in-Human Study in Patients with Mixed Solid Tumors (GO30103).
Authors: Garralda E; Early Drug Development Unit, Vall d'Hebron, Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Oh DY; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul National University College of Medicine, Seoul, Republic of Korea., Italiano A; Early Phase Trials Unit, Institut Bergonié, Bordeaux, and Faculty of Medicine, University of Bordeaux, Bordeaux, France., Bedard PL; Princess Margaret Cancer Centre, University Health Network, Division of Medical Oncology & Hematology, University of Toronto, Toronto, Ontario, Canada., Delord JP; Medical Oncology Department, IUCT Oncopole, Institut Claudius Regaud, Toulouse, France., Calvo E; Centro Integral Oncológico Clara Campal, START Madrid - Clara Campal Comprehensive Cancer Center (CIOCC), Madrid, Spain., LoRusso P; Yale Cancer Center, New Haven, CT, USA., Wainberg Z; University of California Los Angeles, Los Angeles, CA, USA., Cervantes A; Department of Medical Oncology, Hospital Clínico, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain., Rodriguez-Vida A; Hospital del Mar-CIBERONC, IMIM Research Institute, Barcelona, Spain., Shemesh CS; Department of Clinical Pharmacology, Genentech, Inc., South San Francisco, CA, USA., Sane R; Department of Clinical Pharmacology, Genentech, Inc., South San Francisco, CA, USA., Mendus D; Product Development Oncology, Genentech, Inc., South San Francisco, CA, USA., Ding H; Department of Clinical Pharmacology, Genentech, Inc., South San Francisco, CA, USA., Hendricks R; Department of BioAnalytical Sciences, Genentech, Inc., South San Francisco, CA, USA., Meng R; Product Development Oncology, Genentech, Inc., South San Francisco, CA, USA., Cho BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Kim TW; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Wu B; Early Drug Development Unit, Vall d'Hebron, Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul National University College of Medicine, Seoul, Republic of Korea.
Source: Journal of clinical pharmacology [J Clin Pharmacol] 2024 May; Vol. 64 (5), pp. 544-554. Date of Electronic Publication: 2024 Jan 17.
Publication Type: Journal Article; Clinical Trial, Phase I; Research Support, Non-U.S. Gov't; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604 (Electronic) Linking ISSN: 00912700 NLM ISO Abbreviation: J Clin Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38105505
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pharmacokinetics (PK) of Tiragolumab in First-in-Human Study in Patients with Mixed Solid Tumors (GO30103).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Garralda+E%22">Garralda E</searchLink>; Early Drug Development Unit, Vall d'Hebron, Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Oh+DY%22">Oh DY</searchLink>; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul National University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Italiano+A%22">Italiano A</searchLink>; Early Phase Trials Unit, Institut Bergonié, Bordeaux, and Faculty of Medicine, University of Bordeaux, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Bedard+PL%22">Bedard PL</searchLink>; Princess Margaret Cancer Centre, University Health Network, Division of Medical Oncology & Hematology, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Delord+JP%22">Delord JP</searchLink>; Medical Oncology Department, IUCT Oncopole, Institut Claudius Regaud, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Calvo+E%22">Calvo E</searchLink>; Centro Integral Oncológico Clara Campal, START Madrid - Clara Campal Comprehensive Cancer Center (CIOCC), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22LoRusso+P%22">LoRusso P</searchLink>; Yale Cancer Center, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Wainberg+Z%22">Wainberg Z</searchLink>; University of California Los Angeles, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Cervantes+A%22">Cervantes A</searchLink>; Department of Medical Oncology, Hospital Clínico, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Rodriguez-Vida+A%22">Rodriguez-Vida A</searchLink>; Hospital del Mar-CIBERONC, IMIM Research Institute, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Shemesh+CS%22">Shemesh CS</searchLink>; Department of Clinical Pharmacology, Genentech, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Sane+R%22">Sane R</searchLink>; Department of Clinical Pharmacology, Genentech, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Mendus+D%22">Mendus D</searchLink>; Product Development Oncology, Genentech, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ding+H%22">Ding H</searchLink>; Department of Clinical Pharmacology, Genentech, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hendricks+R%22">Hendricks R</searchLink>; Department of BioAnalytical Sciences, Genentech, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Meng+R%22">Meng R</searchLink>; Product Development Oncology, Genentech, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Cho+BC%22">Cho BC</searchLink>; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+TW%22">Kim TW</searchLink>; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Wu+B%22">Wu B</searchLink>; Early Drug Development Unit, Vall d'Hebron, Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul National University College of Medicine, Seoul, Republic of Korea.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220366372%22">Journal of clinical pharmacology</searchLink> [J Clin Pharmacol] 2024 May; Vol. 64 (5), pp. 544-554. <i>Date of Electronic Publication: </i>2024 Jan 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase I; Research Support, Non-U.S. Gov't; Multicenter Study; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0366372 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1552-4604 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200912700%22">00912700 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Pharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38105505
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/jcph.2397
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 544
    Titles:
      – TitleFull: Pharmacokinetics (PK) of Tiragolumab in First-in-Human Study in Patients with Mixed Solid Tumors (GO30103).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Garralda E
      – PersonEntity:
          Name:
            NameFull: Oh DY
      – PersonEntity:
          Name:
            NameFull: Italiano A
      – PersonEntity:
          Name:
            NameFull: Bedard PL
      – PersonEntity:
          Name:
            NameFull: Delord JP
      – PersonEntity:
          Name:
            NameFull: Calvo E
      – PersonEntity:
          Name:
            NameFull: LoRusso P
      – PersonEntity:
          Name:
            NameFull: Wainberg Z
      – PersonEntity:
          Name:
            NameFull: Cervantes A
      – PersonEntity:
          Name:
            NameFull: Rodriguez-Vida A
      – PersonEntity:
          Name:
            NameFull: Shemesh CS
      – PersonEntity:
          Name:
            NameFull: Sane R
      – PersonEntity:
          Name:
            NameFull: Mendus D
      – PersonEntity:
          Name:
            NameFull: Ding H
      – PersonEntity:
          Name:
            NameFull: Hendricks R
      – PersonEntity:
          Name:
            NameFull: Meng R
      – PersonEntity:
          Name:
            NameFull: Cho BC
      – PersonEntity:
          Name:
            NameFull: Kim TW
      – PersonEntity:
          Name:
            NameFull: Wu B
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2024 May
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1552-4604
          Numbering:
            – Type: volume
              Value: 64
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Journal of clinical pharmacology
              Type: main
ResultId 1